Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neutropenia in Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01079676
What this trial is testing

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Who this might be right for
Neutropenia in Breast Cancer
Eurofarma Laboratorios S.A. 220
Large-scale testing (Phase 3)Study completedNCT03343145
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Who this might be right for
Breast Cancer
Dong-A ST Co., Ltd. 143
Testing effectiveness (Phase 2)Ended earlyNCT03559387
What this trial is testing

Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia

Who this might be right for
Chemotherapy-induced Neutropenia
Prolong Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT00001338
What this trial is testing

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsFeverHematologic Diseases+2 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Study completedNCT02005458
What this trial is testing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Who this might be right for
Non Small Cell Lung CancerBreast Cancer
Xiamen Amoytop Biotech Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT03104595
What this trial is testing

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Who this might be right for
Febrile Neutropenia
Enzychem Lifesciences Corporation 28
Not applicableNot Yet RecruitingNCT06076772
What this trial is testing

Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Assiut University 54
Testing effectiveness (Phase 2)Study completedNCT02521441
What this trial is testing

A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.

Who this might be right for
Neutropenia
EVIVE Biotechnology 138
Post-approval studies (Phase 4)Looking for participantsNCT07578064
What this trial is testing

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

Who this might be right for
Breast CancerBone Marrow Suppression
Hongxia Wang 60
Testing effectiveness (Phase 2)Study completedNCT00771433
What this trial is testing

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeutropenia
Centre Francois Baclesse 120
Post-approval studies (Phase 4)UnknownNCT00030758
What this trial is testing

Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer

Who this might be right for
Breast CancerNeutropenia
Anglo Celtic Cooperative Oncology Group 816
Early research (Phase 1)Study completedNCT01484015
What this trial is testing

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Burkitt Lymphoma+36 more
Wake Forest University Health Sciences 70
Large-scale testing (Phase 3)Study completedNCT01735175
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

Who this might be right for
Neutropenic ComplicationsBreast NeoplasmsChemotherapy-induced Neutropenia+1 more
Sandoz 316
Large-scale testing (Phase 3)Study completedNCT00117910
What this trial is testing

Treatment for Elderly Patients With High Risk Breast Cancer

Who this might be right for
Breast Cancer
Amgen
Not applicableStudy completedNCT02728596
What this trial is testing

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

Who this might be right for
Febrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal Cancer+25 more
SWOG Cancer Research Network 3,665
Not applicableUnknownNCT03618810
What this trial is testing

Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer

Who this might be right for
Febrile Neutropenia
Zhejiang Cancer Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT04174599
What this trial is testing

Study to Compare the Efficacy and Safety of F-627 and GRAN®

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 242
Large-scale testing (Phase 3)Study completedNCT02953340
What this trial is testing

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Who this might be right for
NeutropeniaBreast Cancer
Spectrum Pharmaceuticals, Inc 237
Testing effectiveness (Phase 2)Study completedNCT00124111
What this trial is testing

Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Who this might be right for
Breast Cancer
Amgen
Post-approval studies (Phase 4)Study completedNCT00277160
What this trial is testing

Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Who this might be right for
NeutropeniaBreast CancerLung Cancer+2 more
Amgen 852
Next Page